Merit Financial Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,822
Closed -$475K 251
2019
Q3
$475K Buy
2,822
+10
+0.4% +$1.63K 0.05% 89
2019
Q2
$470K Buy
2,812
+105
+4% +$14.5K 0.06% 68
2019
Q1
$396K Buy
2,707
+644
+31% +$93.4K 0.05% 79
2018
Q4
$275K Buy
2,063
+44
+2% +$7.21K 0.04% 90
2018
Q3
$384K Buy
2,019
+19
+1% +$3.49K 0.06% 71
2018
Q2
$333K Buy
2,000
+421
+27% +$67.6K 0.06% 83
2018
Q1
$265K Buy
+1,579
New +$265K 0.05% 93

Other funds holding AGN

Merit Financial Group's AGN Position: Q4 2019 in Review

Merit Financial Group sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 2,822 shares — an estimated $475K sold.

Merit Financial Group first reported a position in AGN in Q1 2018 and held it in 7 quarters. The position peaked at $475K in Q3 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Merit Financial Group reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Merit Financial Group sold 2,822 Allergan plc shares in Q4 2019, an estimated $475K.
  • Merit Financial Group first reported a position in Allergan plc in Q1 2018 and held it in 7 quarters.
  • Merit Financial Group's Allergan plc position peaked at $475K in Q3 2019.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Merit Financial Group's 13F filing for Q4 2019, filed 16 Jan 2020.